ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,475.09
      0.27%
      US Tech 100
      19,276.80
      0.00%
      Dow Jones
      39,169.52
      0.13%
      Brent Oil
      86.605
      0.09%
      Bitcoin
      62,603.22
      -0.39%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU
      6. Sanofi (SAN)

      7. Sanofi (SAN) News

      SAN

      Sanofi (SAN)

      Sanofi
      		Date:
      Sort by:
       Showing the most relevant articles for your search:EU:SAN
      DateTimeSourceHeadlineSymbolCompany
      12/06/20236:13AMDow Jones NewsBOURSE: Merck KGaA chute après l'échec de deux essais sur un traitement de la SEPEU:SANSanofi
      12/06/20235:46AMMF Dow Jones (Italiano)Merck: mancato raggiungimento obiettivo chiave di farmaco controsclerosi multipla dovrebbe pesare su azioni -- Market TalkEU:SANSanofi
      12/06/20235:14AMDow Jones NewsMerck Shares Slump After Multiple Sclerosis Drug Fails in Late-Stage TrialsEU:SANSanofi
      12/05/20231:46AMDow Jones NewsECHO BOURSE: Sanofi déclassé de "surpondérer" à "neutre" par JPMorganEU:SANSanofi
      11/30/20239:23AMDow Jones NewsTeva Closes Collaboration Deal With Sanofi on IBD TreatmentEU:SANSanofi
      11/30/20239:15AMDow Jones NewsSanofi boucle son partenariat avec Teva pour co-développer TEV'574EU:SANSanofi
      11/30/20239:10AMDow Jones NewsSanofi boucle son partenariat avec Teva pour co-développer TEV'574EU:SANSanofi
      11/27/202310:31AMDow Jones NewsTrending: Sanofi's Notus Trial Meets Primary EndpointEU:SANSanofi
      11/27/20238:34AMDow Jones NewsECHO BOURSE: Le Dupixent de Sanofi en passe de devenir un "méga-blockbuster" - CitiEU:SANSanofi
      11/27/20235:59AMMF Dow Jones (Italiano)Dupixent di Sanofi è destinato a diventare un megablockbuster, secondoCiti -- Market TalkEU:SANSanofi
      11/27/20232:40AMDow Jones NewsSanofi Says Notus Phase 3 Trial of Dupixent Met Primary EndpointEU:SANSanofi
      11/27/20232:34AMDow Jones NewsSanofi indique qu'un second essai confirme l'efficacité de Dupixent contre la BPCOEU:SANSanofi
      11/27/20232:29AMDow Jones NewsSanofi indique qu'un second essai confirme l'efficacité de Dupixent contre la BPCOEU:SANSanofi
      11/27/20231:30AMGlobeNewswire Inc.Press Release: Dupixent® significantly reduced COPD exacerbations in second positive Phase 3 trial, accelerating FDA submission and confirming potential to become first approved biologic for this serious diseaseEU:SANSanofi
      11/27/20231:30AMGlobeNewswire Inc.Communiqué de presse : Dupixent® a permis de réduire significativement les exacerbations de BPCO dans le cadre d’un second essai positif de phase III – des résultats qui permettent d’accélérer la soumission à la FDA (...)EU:SANSanofi
      11/27/20231:30AMGlobeNewswire Inc.Press Release: Dupixent® significantly reduced COPD exacerbations in second positive Phase 3 trial, accelerating FDA submission and confirming potential to become first approved biologic for this serious diseaseEU:SANSanofi
      11/27/20231:30AMGlobeNewswire Inc.Dupixent® (dupilumab) Significantly Reduced COPD Exacerbations in Second Positive Phase 3 Trial, Accelerating FDA Submission and Confirming Potential to Become First Approved Biologic for This Serious DiseaseEU:SANSanofi
      11/23/202312:00PMGlobeNewswire Inc.Sanofi: Information concerning the total number of voting rights and shares - October 2023EU:SANSanofi
      11/23/202312:00PMGlobeNewswire Inc.Sanofi: Informations relatives au nombre de droits de vote et d'actions - Octobre 2023EU:SANSanofi
      11/16/20233:12AMDow Jones NewsPRESSE: La santé grand public de Sanofi vaudrait plus de 20 mds de dollars avant l'IPOEU:SANSanofi
      11/16/20233:07AMDow Jones NewsPRESSE: La santé grand public de Sanofi vaudrait plus de 20 mds de dollars avant l'IPOEU:SANSanofi
      11/07/20238:56AMDow Jones NewsSanofi Under Preliminary Probe in France Over Possible Market Manipulation, Source SaysEU:SANSanofi
      11/07/20236:08AMDow Jones NewsUPDATE: Sanofi visé par une enquête du PNF pour manipulation de cours - sourcesEU:SANSanofi
      11/07/20235:20AMDow Jones NewsSanofi visé par une enquête du PNF pour manipulation de cours - sourcesEU:SANSanofi
      11/07/20232:17AMMF Dow Jones (Italiano)L'agenda della settimanaEU:SANSanofi
      10/30/20239:11AMDow Jones NewsSanofi investit 30 millions de dollars dans MeiraGTxEU:SANSanofi
      10/30/20239:06AMDow Jones NewsSanofi investit 30 millions de dollars dans MeiraGTxEU:SANSanofi
      10/30/20238:14AMDow Jones NewsMeiraGTx Gets $30 Million Investment From SanofiEU:SANSanofi
      10/27/202311:47AMDow Jones NewsSanofi Down Over 19%, on Pace for Record Percent Decrease -- Data TalkEU:SANSanofi
      10/27/20234:43AMDow Jones NewsSanofi Shares Tumble After Warning of Profit Hit From Investment, TaxesEU:SANSanofi
       Showing the most relevant articles for your search:EU:SAN